Deferasirox Supplier in Philippines
DEFRATAJ — WHO-GMP Deferasirox dispersible tablets, supplied direct from the manufacturer to FDA Phil-registered importers.
Supply & Market
The Philippines has an established iron-chelation user base with public-sector (PhilHealth) coverage pathways and private specialty-pharmacy distribution. The Food and Drug Administration of the Philippines (FDA-PH) operates an ACTD-harmonised pathway with CPR (Certificate of Product Registration) issuance. Taj Pharma supplies DEFRATAJ Deferasirox dispersible tablets through qualified Philippine distributors.
Supply to the Philippines is via CIF Manila port (typical sea transit 10-16 days from Mumbai/Nhava Sheva) or Manila / Cebu airfreight (3-5 days). English-language packaging is standard and accepted by FDA-PH with Philippines-specific Module 1 administrative content. Tagalog-language patient-information inserts can be prepared on request for private pharmacy channels.
FDA-PH registration follows the ACTD format. Submission includes Module 1 (Philippine-specific administrative, proposed Philippine SmPC/PIL and carton), Module 2-5 (quality, non-clinical, clinical including BE). CPR validity is typically 5 years with renewal. Post-approval variations are managed through a defined category system. Typical registration timeline 12-24 months; expedited review may apply for public-health priority products.